We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $303B
1-Year Est. Return 53.02%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+15.15%
1 Year Est. Return
+53.02%
3 Year Est. Return
+141.18%
5 Year Est. Return
+166.47%
10 Year Est. Return
+624.92%
AUM
$204B
AUM Growth
+$7.93B
Cap. Flow
-$14.6B
Cap. Flow %
-7.18%
Top 10 Hldgs %
19.82%
Holding
6,003
New
468
Increased
1,653
Reduced
2,974
Closed
377

Sector Composition

Rank Sector Weight
1 Technology 20.55%
2 Financials 7.82%
3 Consumer Discretionary 7.65%
4 Communication Services 5.12%
5 Healthcare 5.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CING icon
5201
Cingulate
CING
$71.1M
$1.27K ﹤0.01%
+311
New +$1.27K
ESLAW icon
5202
CALL
Estrella Immunopharma Warrant
ESLAW
$138K
$1.24K ﹤0.01%
30,000
AKYA
5203
DELISTED
Akoya BioSciences
AKYA
$1.21K ﹤0.01%
931
-18,647
-95% -$22.4K
RILY icon
5204
BRC Group Holdings
RILY
$285M
$1.21K ﹤0.01%
407
-15,024
-97% -$46.2K
ADIL
5205
Adial Pharmaceuticals
ADIL
$8.91M
$1.2K ﹤0.01%
+159
New +$2.4K
RGC icon
5206
Regencell Bioscience
RGC
$2.75B
$1.19K ﹤0.01%
+70
New +$854
ANY icon
5207
Sphere 3D
ANY
$15.7M
$1.19K ﹤0.01%
+201
New +$1.28K
OSS icon
5208
One Stop Systems
OSS
$325M
$1.17K ﹤0.01%
+330
New +$921
COSM icon
5209
Cosmos Holdings
COSM
$14.7M
$1.13K ﹤0.01%
+2,678
New +$1.13K
DYNF icon
5210
BlackRock US Equity Factor Rotation ETF
DYNF
$40.2B
$1.09K ﹤0.01%
+20
New +$1K
IFRX icon
5211
InflaRx
IFRX
$271M
$1.03K ﹤0.01%
1,301
OMEX icon
5212
Odyssey Marine Exploration
OMEX
$52.5M
$1K ﹤0.01%
+851
New +$775
MBIO icon
5213
Mustang Bio
MBIO
$4.39M
$961 ﹤0.01%
+1,006
New +$1.22K
IPM
5214
Intelligent Protection Management Corp
IPM
$24.2M
$954 ﹤0.01%
+505
New +$970
LVO icon
5215
LiveOne
LVO
$60.2M
$932 ﹤0.01%
124
-5,102
-98% -$37.9K
AIFF
5216
Firefly Neuroscience
AIFF
$18.6M
$914 ﹤0.01%
+323
New +$1.02K
APM
5217
DELISTED
Aptorum Group
APM
$907 ﹤0.01%
995
+976
+5,137% +$920
REKR icon
5218
Rekor Systems
REKR
$94.4M
$899 ﹤0.01%
775
-52,783
-99% -$55.4K
UITB icon
5219
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
$2.65B
$894 ﹤0.01%
+19
New +$884
SOPA
5220
DELISTED
Society Pass
SOPA
$886 ﹤0.01%
+642
New +$715
HAUZ icon
5221
Xtrackers International Real Estate ETF
HAUZ
$1.07B
$869 ﹤0.01%
38
CNYA icon
5222
iShares MSCI China A ETF
CNYA
$208M
$861 ﹤0.01%
30
-15
-33% -$416
JYD icon
5223
Jayud Global Logistics
JYD
$7.72M
$841 ﹤0.01%
+83
New +$1.56K
SMXT icon
5224
Solarmax Technology
SMXT
$21.1M
$834 ﹤0.01%
765
-20,326
-96% -$23.1K
KAVL
5225
DELISTED
Kaival Brands Innovations Group
KAVL
$819 ﹤0.01%
+1,659
New +$898

Similar funds

Citigroup's Q2 2025 Portfolio in Review

As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Citigroup withdrew a net $14.6B in Q2 2025, closing 377 positions and reducing 2,974 holdings. Its most notable exit was James Hardie Industries, an estimated $125M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Citigroup opened a new position in Amrize Ltd worth $114M.

  • Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
  • Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
  • Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
  • Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
  • Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
  • Citigroup opened 468 new positions and closed 377 in Q2 2025.
  • Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.

Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.